Olfactory ensheathing cells	1
the tissue loss but not the cavity formation	40
the tissue loss	40
the cavity formation	64
spinal cord of rats Bing Cang Li a , b , , Yue Li c , Li Fa Chen d , Jie Yuan Chang a , b , Zhao Xiao Duan a , b a Research Institute of Surgery , Daping Hospital , Third Military Medical University , Chongqing 400042 , China b State Key Laboratory of Trauma , Burn and Combined Injury , Chongqing 400042 , China c Department of minimal invasive neurosurgery of the first affiliated hospital , Kunming Medical University , Kunming , 650032 , China d Physiological department , Chongqing Medical University , Chongqing 400042 ,	97
spinal cord	97
rats	112
Bing Cang Li a , b ,	118
Bing Cang	118
Li a , b ,	128
Li a	128
b	133
Yue Li c	138
Li Fa Chen d	148
Li Fa Chen	148
d	159
Jie Yuan Chang a	162
Jie Yuan Chang	162
a	177
b	179
Zhao Xiao Duan a	182
Zhao Xiao Duan	182
a	197
b a Research Institute of Surgery	199
b	199
a Research Institute of Surgery	201
a Research Institute	201
Surgery	225
Daping Hospital	234
Third Military Medical University	251
Chongqing 400042	286
China b State Key Laboratory of Trauma , Burn and Combined Injury	304
China b State Key Laboratory	304
Trauma , Burn and Combined Injury	336
Chongqing 400042	370
China c Department of minimal invasive neurosurgery of the first affiliated hospital	388
China c Department	388
minimal invasive neurosurgery of the first affiliated hospital	410
minimal invasive neurosurgery	410
the first affiliated hospital	443
Kunming Medical University	474
Kunming	502
650032	511
China d Physiological department	519
Chongqing Medical University	553
Chongqing 400042	582
China a b s t r a c t In recent years , olfactory ensheathing cells -LRB- OECs -RRB- have been used as a therapeutic strategy to repair the anatomical structure and promote the function recovery of injured spinal cord in both animal and human	600
China	600
a b	608
t r a c t In recent years , olfactory ensheathing cells -LRB- OECs -RRB- have been used as a therapeutic strategy to repair the anatomical structure and promote the function recovery of injured spinal cord in both animal and human	614
t r	614
a c t	618
recent years	627
olfactory ensheathing cells -LRB- OECs -RRB-	641
olfactory ensheathing cells	641
OECs	670
a therapeutic strategy	694
the anatomical structure	727
the function recovery of injured spinal cord	764
the function recovery	764
injured spinal cord	789
both animal and human	812
animal	817
human	828
this study	838
OECs	850
contused spinal cords of adult rats	878
contused spinal cords	878
adult rats	903
dorsal laminectomy at T10 vertebra	921
dorsal laminectomy	921
T10 vertebra	943
spinal cord	957
a force of 10 g with NYU II impactor from 25 mmabove	984
a force	984
10 g with NYU II impactor from 25 mmabove	995
10 g	995
NYU II impactor from 25 mmabove	1005
NYU II impactor	1005
25 mmabove	1026
the exposed cord	1037
The contused spinal cord	1055
The	1055
spinal cord	1068
injections of OECs in DMEM or DMEM	1089
injections	1089
OECs in DMEM or DMEM	1103
OECs	1103
DMEM or DMEM	1111
one week after injury	1133
one week	1133
injury	1148
The migration and distribution of OECs in the contused spinal cord	1156
The migration and distribution	1156
OECs in the contused spinal cord	1190
OECs	1190
the contused spinal cord	1198
the	1198
spinal cord	1211
the light microscope	1240
The intact tissue area , injured tissue area , cavity size , number of myelinated nerve fibers and neurons labeled by CB-HRP in T8 segment	1262
The intact tissue area	1262
tissue area , cavity size , number of myelinated nerve fibers and neurons labeled by CB-HRP in T8 segment	1294
tissue area	1294
cavity size	1307
number of myelinated nerve fibers	1320
number	1320
myelinated nerve fibers	1330
neurons labeled by CB-HRP in T8 segment	1358
neurons	1358
CB-HRP in T8 segment	1377
CB-HRP	1377
T8 segment	1387
the semi-quantitative techniques at 6 weeks after transplantation	1427
the semi-quantitative techniques	1427
6 weeks after transplantation	1463
6 weeks	1463
transplantation	1477
Locomotor ability and conductive function of the spinal cord	1494
Locomotor ability and conductive function	1494
the spinal cord	1539
the BBB score	1573
cortical somatosensory	1591
potentials -LRB- CSEP -RRB- recording	1621
potentials -LRB- CSEP -RRB-	1621
potentials	1621
CSEP	1633
OECs	1650
both lesion site and tissue	1669
lesion site	1674
tissue	1690
the lesion	1702
The intact tissue area	1714
the OECs-transplanted rats	1765
that in the DMEM-injected animals	1797
that	1797
the DMEM-injected animals	1805
the injured tissue area	1840
the OECs-rats	1893
that in the DMEM-rats	1912
that	1912
the DMEM-rats	1920
The number of myelinated nerve fibers in the lesion site and preserved neurons in T8	1935
The number	1935
myelinated nerve fibers in the lesion site and preserved neurons in T8	1949
myelinated nerve fibers in the lesion site	1949
myelinated nerve fibers	1949
the lesion site	1976
preserved neurons in T8	1996
preserved neurons	1996
T8	2017
the OECs-group	2049
the DMEM-group	2072
the cavity size	2092
the two groups	2157
The BBB score and CSEP recording	2173
a better performance of locomotor ability and conductive function in the OECs-transplanted rats	2213
a better performance of locomotor ability	2213
a better performance	2213
locomotor ability	2237
conductive function in the OECs-transplanted rats	2259
conductive function	2259
the OECs-transplanted rats	2282
the DMEMinjected animals	2317
These results	2343
OECs	2371
secondary tissue degeneration	2391
spinal cord injury	2427
they	2456
the cavity formation	2475
they	2497
morphological preservation and functional improvement of the contused spinal cord	2514
morphological preservation and functional improvement	2514
the contused spinal cord	2571
the	2571
spinal cord	2584
Introduction	2601
the axons in the peripheral nervous system -LRB- PNS -RRB-	2621
the axons	2621
the peripheral nervous system -LRB- PNS -RRB-	2634
the peripheral nervous system	2634
PNS	2665
axons confined within the central nervous system -LRB- CNS -RRB-	2671
axons	2671
the central nervous system	2693
CNS	2721
their targets	2775
This	2790
lack of a permissive environment and active inhibitory molecules that are rich in the CNS but quite a few in the PNS	2821
lack of a permissive environment	2821
lack	2821
a permissive environment	2829
active inhibitory molecules that are rich in the CNS but quite a few in the PNS	2858
active inhibitory molecules	2858
the CNS but quite a few in the PNS	2903
the CNS	2903
quite a few in the PNS	2915
quite a few	2915
the PNS	2930
the adult mammalian olfactory system	2942
successful axonal growth and regeneration	2989
successful axonal growth	2989
regeneration	3018
large part	3050
olfactory ensheathing cells -LRB- OECs -RRB- , a unique population of glial cells exhibiting antigenic and morphologic characteristics of astrocytes , Schwann cells , and oligodendrocytes and the expression of an array of neurotrophic factors and extracellular matrix molecules -LSB- 1	3065
olfactory ensheathing cells -LRB- OECs -RRB-	3065
olfactory ensheathing cells	3065
OECs	3094
a unique population of glial cells exhibiting antigenic and morphologic characteristics of astrocytes , Schwann cells , and oligodendrocytes and the expression of an array of neurotrophic factors and extracellular matrix molecules -LSB- 1	3101
a unique population	3101
glial cells exhibiting antigenic and morphologic characteristics of astrocytes , Schwann cells , and oligodendrocytes and the expression of an array of neurotrophic factors and extracellular matrix molecules -LSB- 1	3124
glial cells	3124
antigenic and morphologic characteristics of astrocytes , Schwann cells , and oligodendrocytes and the expression of an array of neurotrophic factors and extracellular matrix molecules -LSB- 1	3147
antigenic and morphologic characteristics of astrocytes , Schwann cells , and oligodendrocytes	3147
antigenic and morphologic characteristics	3147
astrocytes , Schwann cells , and oligodendrocytes	3192
astrocytes	3192
Schwann cells	3204
oligodendrocytes	3223
the expression of an array of neurotrophic factors and extracellular matrix molecules -LSB- 1	3244
the expression	3244
an array of neurotrophic factors and extracellular matrix molecules -LSB- 1	3262
an array of neurotrophic factors	3262
an array	3262
neurotrophic factors	3274
extracellular matrix molecules -LSB- 1	3299
extracellular matrix molecules	3299
1	3331
3 -RSB-	3333
OECs	3337
regeneration of sensory and descending axons and recovery of function	3369
regeneration	3369
sensory and descending axons and recovery of function	3385
sensory and descending axons	3385
sensory	3385
descending axons	3397
recovery of function	3418
recovery	3418
function	3430
varying degrees	3442
the lesion site of spinal cord injury -LRB- SCI -RRB- such as thoracic spinal transection , fine electrolytic lesion , hemisection , and moderate contusion in adult rats -LSB- 4 -- 6 -RSB-	3479
the lesion site	3479
spinal cord injury -LRB- SCI -RRB- such as thoracic spinal transection , fine electrolytic lesion , hemisection , and moderate contusion in adult rats -LSB- 4 -- 6 -RSB-	3498
spinal cord injury -LRB- SCI -RRB-	3498
spinal cord injury	3498
SCI	3518
thoracic spinal transection , fine electrolytic lesion , hemisection , and moderate contusion in adult rats -LSB- 4 -- 6 -RSB-	3531
thoracic spinal transection	3531
fine electrolytic lesion	3560
hemisection	3586
moderate contusion in adult rats -LSB- 4	3603
moderate contusion	3603
adult rats -LSB- 4	3625
adult rats	3625
4	3637
6 -RSB-	3639
addition	3646
OECs	3656
transplant donor cells for human SCI therapies	3679
transplant donor cells	3679
human SCI therapies	3706
China , Australia , and Portugal	3729
7	3761
12 -RSB-	3763
grafting of OECs in human SCI patients	3777
grafting	3777
OECs in human SCI patients	3789
OECs	3789
human SCI patients	3797
the results from these trials	3849
the results	3849
these trials	3866
preliminary due to the potential for spontaneous recovery and the limited number of trial patients	3900
the potential for spontaneous recovery	3919
the potential	3919
spontaneous recovery	3937
the limited number of trial	3962
the limited number	3962
trial	3984
experiments -LSB- 12 -RSB-	4025
experiments	4025
12 -RSB-	4038
unknown phenotypes and fate of OECs , perioperative morbidity and lack of functional benefits	4048
unknown phenotypes	4048
fate of OECs , perioperative morbidity and lack of functional benefits	4071
fate	4071
OECs , perioperative morbidity and lack	4079
OECs	4079
perioperative morbidity	4085
lack	4113
functional benefits	4121
very serious shortcomings -LSB- 13 -RSB-	4145
very serious shortcomings	4145
13 -RSB-	4172
The abilities of OECs to promote regeneration of central axons and functional recovery after spinal cord injuries	4177
The abilities	4177
OECs to promote regeneration of central axons and functional recovery after spinal cord injuries	4194
regeneration of central axons and functional recovery	4210
regeneration	4210
central axons and functional recovery	4226
central axons	4226
functional recovery	4244
spinal cord injuries	4270
their expression of nerve growth factor -LRB- NGF -RRB- , brain-derived neurotrophic factor -LRB- BDNF -RRB- , glial cell line-derived neurotrophic factor -LRB- GDNF -RRB- , and neurotrophin 4/5 -LRB- NT-4 / 5 -RRB- -LSB- 14,15 -RSB-	4311
their expression	4311
nerve growth factor -LRB- NGF -RRB- , brain-derived neurotrophic factor -LRB- BDNF -RRB- , glial cell line-derived neurotrophic factor -LRB- GDNF -RRB- , and neurotrophin 4/5 -LRB- NT-4 / 5 -RRB- -LSB- 14,15 -RSB-	4331
nerve growth factor -LRB- NGF -RRB- , brain-derived neurotrophic factor -LRB- BDNF -RRB- , glial cell line-derived neurotrophic factor -LRB- GDNF -RRB- , and neurotrophin 4/5 -LRB- NT-4 / 5 -RRB-	4331
nerve growth factor -LRB- NGF -RRB-	4331
nerve growth factor	4331
NGF	4352
brain-derived neurotrophic factor -LRB- BDNF -RRB-	4358
brain-derived neurotrophic factor	4358
BDNF	4393
glial cell line-derived neurotrophic factor -LRB- GDNF -RRB-	4400
glial cell	4400
line-derived neurotrophic factor -LRB- GDNF -RRB-	4411
line-derived neurotrophic factor	4411
GDNF	4445
neurotrophin 4/5 -LRB- NT-4 / 5 -RRB-	4456
neurotrophin 4/5	4456
NT-4	4474
14,15 -RSB-	4483
sensory axons	4509
NGF , BDNF , and neurotrophin	4541
NGF	4541
BDNF	4546
neurotrophin	4556
3 -LRB- NT-3 -RRB- -LSB- 12,15 -RSB-	4569
3	4569
NT-3	4572
12,15 -RSB-	4579
lesioned rubrospinal and corticospinal axons	4592
lesioned rubrospinal	4592
corticospinal axons	4617
BDNF -LSB- 16 -- 18 -RSB-	4655
BDNF	4655
16 -- 18	4661
NT-4	4669
5	4674
atrophy of rat rubrospinal neurons	4685
atrophy	4685
rat rubrospinal neurons	4696
axotomy	4726
rubrospinal regeneration	4747
19 -RSB-	4773
GDNF	4778
survival and axonal regeneration of noradrenergic neurons of the locus coeruleus -LSB- 20,21 -RSB-	4792
survival and axonal regeneration	4792
noradrenergic neurons of the locus coeruleus -LSB- 20,21 -RSB-	4828
noradrenergic neurons	4828
the locus coeruleus -LSB- 20,21 -RSB-	4853
the locus coeruleus	4853
20,21 -RSB-	4874
OECs	4891
IL1 , laminin , N-CAM , PSANCAM , and fibronectin which are involved in neurite extension -LSB- 1 -RSB-	4904
IL1 , laminin , N-CAM , PSANCAM , and fibronectin	4904
neurite extension -LSB- 1 -RSB-	4972
neurite extension	4972
1 -RSB-	4991
Contusive injury of spinal cord	4995
Contusive injury	4995
spinal cord	5015
a common type of damage in humans -LSB- 22,23 -RSB- , in which many damaging tissue processes are initiated , including the release of excessive excitatory amino acids , Ca + + and oxygen free-radical that lead to secondary tissue loss -LSB- 24 -RSB-	5030
a common type	5030
damage in humans -LSB- 22,23 -RSB- , in which many damaging tissue processes are initiated , including the release of excessive excitatory amino acids , Ca + + and oxygen free-radical that lead to secondary tissue loss -LSB- 24 -RSB-	5047
damage	5047
humans -LSB- 22,23 -RSB- , in which many damaging tissue processes are initiated , including the release of excessive excitatory amino acids , Ca + + and oxygen free-radical that lead to secondary tissue loss -LSB- 24 -RSB-	5057
humans	5057
22,23 -RSB- , in which many damaging tissue processes are initiated , including the release of excessive excitatory amino acids , Ca + + and oxygen free-radical that lead to secondary tissue loss -LSB- 24 -RSB-	5065
22,23 -RSB-	5065
many damaging tissue processes	5082
the release of excessive excitatory amino acids , Ca +	5138
the release	5138
excessive excitatory amino acids , Ca +	5153
excessive excitatory amino acids	5153
Ca +	5187
Ca	5187
+	5189
oxygen free-radical that lead to secondary tissue loss	5196
oxygen free-radical	5196
lead	5221
secondary tissue loss	5229
24 -RSB-	5252
addition to these changes	5260
addition	5260
these changes	5272
substances inhibitory to axon regeneration	5287
substances	5287
regeneration	5317
a barrier	5340
growth	5358
sustenance for surviving nerve cells	5366
sustenance	5366
surviving nerve cells	5381
cavities	5422
25 -RSB-	5437
it	5448
the spread of secondary tissue loss	5472
the spread	5472
secondary tissue loss	5486
formation of the scar and cavity	5516
formation	5516
the scar and cavity	5529
nerve fiber growth across the area of injury	5562
nerve fiber growth	5562
the area of injury	5588
the area	5588
injury	5600
the contused spinal cord of rats	5614
the	5614
spinal cord of rats	5627
spinal cord	5627
rats	5642
a model of grafting and to study the effects of green fluorescence protein -LRB- GFP -RRB- transcribed OECs acutely isolated from olfactory bulb of rats on the anatomical structure and functional recovery of the contused cord	5659
a model	5659
grafting and to study the effects of green fluorescence protein -LRB- GFP -RRB- transcribed OECs acutely isolated from olfactory bulb of rats on the anatomical structure and functional recovery of the contused cord	5670
the effects of green fluorescence protein -LRB- GFP -RRB- transcribed OECs acutely isolated from olfactory bulb of rats on the anatomical structure and functional recovery of the contused cord	5692
the effects	5692
green fluorescence protein -LRB- GFP -RRB- transcribed OECs acutely isolated from olfactory bulb of rats on the anatomical structure and functional recovery of the contused cord	5707
green fluorescence protein	5707
GFP	5735
OECs acutely isolated	5752
OECs	5752
olfactory bulb of rats on the anatomical structure and functional recovery of the contused cord	5779
olfactory bulb of rats on the anatomical structure	5779
olfactory bulb	5779
rats on the anatomical structure	5797
rats	5797
the anatomical structure	5805
functional recovery of the contused cord	5834
functional recovery	5834
the contused cord	5857
the	5857
cord	5870
It	5876
OECs	5908
the intact tissue	5923
locomotor function	5954
the formation of cavity	5995
the formation	5995
cavity	6012
the contused spinal cord	6026
the	6026
spinal cord	6039
These results	6052
human SCI therapy	6089
the future	6110
Materials and methods 2.1 .	6126
Materials and methods 2.1	6126
Materials	6126
methods 2.1	6140
Preparation of OECs from GFP rats OECs	6153
Preparation	6153
OECs from GFP rats OECs	6168
OECs	6168
GFP rats OECs	6178
the nerve fiber layer of the olfactory bulb of adult GFP rats as previously described -LRB- Sasaki et al. , 2004 . -RRB-	6211
the nerve fiber layer	6211
the olfactory bulb of adult GFP rats as previously described -LRB- Sasaki et al. , 2004 . -RRB-	6236
the olfactory bulb	6236
adult GFP rats as previously described -LRB- Sasaki et al. , 2004 . -RRB-	6258
adult GFP rats	6258
Sasaki et al. , 2004	6298
Sasaki	6298
et al.	6305
2004	6313
.	6319
the caudal 2/3 of the olfactory bulbs	6330
the caudal 2/3	6330
the olfactory bulbs	6348
meninges and white matter	6390
meninges	6390
white matter	6403
scalpel blades	6429
25 min in collagenase A -LRB- 0.75 mg/ml , Roche , Basel , Basel-Stadt , Swiss -RRB- , collagenase D -LRB- 0.75 mg/ml , Roche , Basel , Basel-Stadt , Swiss -RRB- and papain -LRB- 12 units/ml , Worthinton , Freehold , NJ , USA -RRB-	6462
25 min	6462
collagenase A -LRB- 0.75 mg/ml , Roche , Basel , Basel-Stadt , Swiss -RRB- , collagenase D -LRB- 0.75 mg/ml , Roche , Basel , Basel-Stadt , Swiss -RRB- and papain -LRB- 12 units/ml , Worthinton , Freehold , NJ , USA -RRB-	6472
collagenase A -LRB- 0.75 mg/ml , Roche , Basel , Basel-Stadt , Swiss -RRB-	6472
collagenase A	6472
0.75 mg/ml	6487
Roche , Basel	6499
Basel-Stadt , Swiss	6513
collagenase D -LRB- 0.75 mg/ml , Roche , Basel , Basel-Stadt , Swiss -RRB-	6534
collagenase D	6534
0.75 mg/ml	6549
Roche , Basel	6561
Basel-Stadt , Swiss	6575
papain -LRB- 12 units/ml , Worthinton , Freehold , NJ , USA -RRB-	6599
papain	6599
12 units/ml	6607
Worthinton , Freehold	6620
NJ , USA	6642
calciumfree complete saline solution	6654
trace cysteine at 37 °C on a rotary shaker in a CO2 incubator	6696
trace cysteine	6696
37 °C on a rotary shaker in a CO2 incubator	6714
37 °C	6714
a rotary shaker in a CO2 incubator	6723
a rotary shaker	6723
a CO2 incubator	6742
Tissue	6759
very gentle mechanical trituration , washed and plated in a culture flask for 1 h in DMEM with 10 % FCS before removing and washing nonadherent cells	6792
very gentle mechanical trituration	6792
a culture flask for 1 h in DMEM	6849
a culture flask	6849
1 h in DMEM	6869
1 h	6869
DMEM	6876
10 % FCS	6886
nonadherent cells	6922
Cells	6941
3 times in DMEM	6959
3 times	6959
DMEM	6970
FCS	6983
a final concentration of 30,000 cells per micro liter	6990
a final concentration	6990
30,000 cells per micro liter	7015
30,000 cells	7015
micro liter	7032
identification	7049
the isolated cells	7065
poly-L-lysine coated chamber slide	7110
DMEM	7161
10 % FCS and penicillin/streptomycin	7171
5 -- 7 days	7214
5	7214
7 days	7216
cells	7224
ice-cold methanol	7246
primary antibodies rabbit anti-p75 -LRB- Chemicon , Temecula , CA , USA -RRB- and mouse anti S-100 -LRB- Chemicon , Temecula , CA , USA -RRB-	7281
primary antibodies rabbit anti-p75	7281
Chemicon	7317
Temecula	7327
CA , USA	7337
mouse anti S-100	7350
Chemicon	7368
Temecula	7378
CA , USA	7388
secondary antibodies Alexiflour488 goat anti-mouse -LRB- 1:1000 -RRB- and Alexiflour594 goat antirabbit -LRB- 1:1000 -RRB-	7417
secondary antibodies Alexiflour488 goat anti-mouse -LRB- 1:1000 -RRB-	7417
secondary antibodies Alexiflour488 goat	7417
1:1000	7469
Alexiflour594 goat antirabbit -LRB- 1:1000 -RRB-	7481
Alexiflour594 goat antirabbit	7481
1:1000	7512
Hoechst 33358 -LRB- 1:1000 -RRB-	7544
Hoechst 33358	7544
1:1000	7559
Molecular Probes , Eugene , OR , USA	7576
Molecular Probes	7576
Eugene	7594
OR	7602
USA	7606
Antibody staining	7611
at least 95 % of donor cells	7654
at least 95 %	7654
donor cells	7670
P75 and S-100	7705
2.2	7720
Contusion injury Adult male Sprague Dawley -LRB- SD -RRB- rats -LRB- 200 -- 250 g -RRB- were housed according to the Third Military Medical University -LRB- TMMU -RRB- guidelines , and surgical procedures and post-op carewere	7725
Contusion injury Adult	7725
male Sprague Dawley -LRB- SD -RRB- rats -LRB- 200 -- 250 g -RRB-	7748
male Sprague Dawley -LRB- SD -RRB- rats	7748
male Sprague Dawley	7748
SD	7769
rats	7773
200 -- 250 g	7779
200	7779
250 g	7783
the Third Military Medical University -LRB- TMMU -RRB- guidelines , and surgical procedures and post-op carewere	7815
the Third Military Medical University -LRB- TMMU -RRB- guidelines	7815
TMMU	7854
surgical procedures and post-op carewere	7876
surgical procedures	7876
post-op carewere	7900
accordance	7930
protocols approved by TMMU Institutional Animal Care and Use Committee	7946
protocols	7946
TMMU Institutional Animal Care and Use Committee	7968
Rats	8018
a single intraperitoneal injection of 3 % sodium pentobarbiturate -LRB- 40 -- 50 mg/kg -RRB-	8046
a single intraperitoneal injection	8046
3 % sodium pentobarbiturate -LRB- 40 -- 50 mg/kg -RRB-	8084
3 % sodium pentobarbiturate	8084
40 -- 50 mg/kg	8112
40	8112
50 mg/kg	8115
a sterile laminectomy	8130
vertebral levels T10	8169
the dura	8209
The spinal cords	8219
an NYU-II impactor	8256
a dropping weight -LRB- 10.0 g -RRB- from 25 mm above the exposed cord -LSB- 26 -RSB-	8280
a dropping weight -LRB- 10.0 g -RRB-	8280
a dropping weight	8280
10.0 g	8299
25 mm above the exposed cord -LSB- 26 -RSB-	8312
25 mm	8312
the exposed cord -LSB- 26 -RSB-	8323
the exposed cord	8323
26 -RSB-	8341
injury	8352
the muscles and skin	8359
layers	8395
The procedure	8403
hind limb paralysis	8429
all animals	8452
wound and bladder infections	8476
Bicillin -LRB- 60000 U/kg , i.m. -RRB-	8506
Bicillin	8506
60000 U/kg , i.m.	8516
60000 U/kg	8516
i.m.	8528
7 days and bladder expression	8554
7 days	8554
bladder expression	8565
7 days	8614
contusion	8627
2.3	8638
OECs transplantation Seven days after the initial surgery , the spinal cordswere	8643
OECs transplantation	8643
Seven days	8664
the initial surgery , the spinal cordswere	8681
the initial surgery	8681
the spinal cordswere	8702
anesthesia	8740
the same site	8754
1 μl	8769
30,000 cells	8775
suspension	8789
the midline of the contused cord at a depth of 0.8 mm at the epicenter of the lesion and 1 mm rostral and caudal to the epicenter for a total of 3 μl of cell suspension -LRB- 90,000 cells -RRB-	8819
the midline	8819
the contused cord at a depth of 0.8 mm at the epicenter of the lesion and 1 mm rostral and caudal to the epicenter for a total of 3 μl of cell suspension -LRB- 90,000 cells -RRB-	8834
the	8834
cord at a depth of 0.8 mm	8847
cord	8847
a depth of 0.8 mm	8855
a depth	8855
0.8 mm	8866
the epicenter of the lesion and 1 mm rostral and caudal	8876
the epicenter of the lesion	8876
the epicenter	8876
the lesion	8893
1 mm rostral and caudal	8908
1 mm rostral	8908
caudal	8925
the epicenter for a total of 3 μl of cell suspension -LRB- 90,000 cells -RRB-	8935
the epicenter	8935
a total of 3 μl of cell suspension -LRB- 90,000 cells -RRB-	8953
a total	8953
3 μl of cell suspension -LRB- 90,000 cells -RRB-	8964
3 μl	8964
cell suspension -LRB- 90,000 cells -RRB-	8972
cell suspension	8972
90,000 cells	8989
The cell injections	9005
a drawn glass micropipette	9046
the pipette	9078
place for 5 min	9102
place	9102
5 min	9112
each injection	9124
Control animals	9140
equal volumes of DMEM	9165
equal volumes	9165
DMEM	9182
the same sites	9196
the injection	9218
the muscle and skin	9233
interrupted sutures	9270
Rats -LRB- n = 5 at each time point -RRB-	9291
Rats	9291
n = 5 at each time point	9297
n = 5	9297
n	9297
5	9299
each time point	9304
weeks 1 -- 5	9339
weeks	9339
1 -- 5	9345
n = 10	9354
n	9354
= 10	9355
week 6	9364
2.4	9372
Histological procedures and quantification	9377
1 , 2 , 3 , 4 , 5 , and 6 weeks after transplantation	9423
1	9423
2	9426
3	9429
4	9432
5	9435
6 weeks after transplantation	9442
6 weeks	9442
transplantation	9456
the rats	9472
physiological saline , followed by 4 % paraformaldehyde for frozen sectioning or 2 % paraformaldehyde and 2 % glutaraldehyde in PBS -LRB- pH 7.4 -RRB- for plastic embedding and sectioning	9515
physiological saline	9515
4 % paraformaldehyde for frozen sectioning or 2 % paraformaldehyde and 2 % glutaraldehyde	9549
4 % paraformaldehyde for frozen sectioning	9549
4 % paraformaldehyde	9549
frozen sectioning	9573
2 % paraformaldehyde and 2 % glutaraldehyde	9594
2 % paraformaldehyde	9594
2 % glutaraldehyde	9618
PBS -LRB- pH 7.4 -RRB- for plastic embedding and sectioning	9639
PBS -LRB- pH 7.4 -RRB-	9639
PBS	9639
pH 7.4	9644
plastic embedding and sectioning	9656
spinal cords	9703
4 % paraformaldehyde for frozen sections or 3 % glutaraldehyde for plastic sections	9747
4 % paraformaldehyde for frozen sections	9747
4 % paraformaldehyde	9747
frozen sections	9771
3 % glutaraldehyde for plastic sections	9790
3 % glutaraldehyde	9790
plastic sections	9812
Frozen longitudinal serial sections of complete cords	9830
Frozen longitudinal serial sections	9830
complete cords	9869
a thickness of 15 μm on a LEICA Cryostat	9896
a thickness	9896
15 μm on a LEICA Cryostat	9911
15 μm	9911
a LEICA Cryostat	9920
a heating plate	9947
Aqua Poly/Mount -LRB- Polysciences , Inc. , Warrington , FL , USA -RRB-	9980
Aqua Poly/Mount	9980
Polysciences , Inc. , Warrington , FL , USA	9997
Polysciences	9997
Inc.	10011
Warrington	10017
FL	10029
USA	10033
The sections	10039
Olympus fluorescence microscope	10072
DP71 digital camera and software	10126
DP71 digital camera	10126
software	10150
All lesions	10160
both FITC and Rhodamine excitation wavelengths	10189
FITC	10194
Rhodamine excitation wavelengths	10203
OECs -LRB- which fluoresce only in the green wavelength -RRB- and macrophages that autoflouresce in all wavelengths	10259
OECs -LRB- which fluoresce only in the green wavelength -RRB-	10259
OECs	10259
the green wavelength	10289
macrophages that autoflouresce in all wavelengths	10315
macrophages	10315
all wavelengths	10349
The digital images	10366
10 × or 20 ×	10403
10 ×	10403
20 ×	10410
Coronal semi-thin plastic sections -LRB- 1 μm -RRB-	10415
Coronal semi-thin plastic sections	10415
1 μm	10451
tissue block osmicated , dehydrated and embedded for standard plastic embedding	10477
tissue block	10477
standard plastic embedding	10529
Sections	10557
methylene blue / Azure II	10584
methylene blue	10584
Azure II	10600
Olympus BX50 microscope	10628
The number of the myelinated nerve fibers in the lesion site	10653
The number	10653
the myelinated nerve fibers in the lesion site	10667
the myelinated nerve fibers	10667
the lesion site	10698
5 digital photographs taken from different serial coronal sections under 40 × microscope -LRB- 0.029 mm2 -RRB- per animal	10729
5 digital photographs	10729
different serial coronal sections under 40 × microscope -LRB- 0.029 mm2 -RRB- per animal	10762
different serial coronal sections	10762
40 × microscope -LRB- 0.029 mm2 -RRB-	10802
40 × microscope	10802
0.029 mm2	10818
animal	10833
The areas of intact and injured tissues including cavities	10841
The areas	10841
intact and injured tissues including cavities	10854
intact and injured tissues	10854
cavities	10891
5 serial coronal sections	10917
a section-to-section interval of 100 μm using Spot 345 software	10948
a section-to-section interval	10948
100 μm using Spot 345 software	10981
100 μm	10981
Spot 345 software	10994
These 5 measurements	11013
the relative quantification data	11069
each animal	11106
2.5	11119
Retrograde labeling of the spinal neurons	11124
Retrograde labeling	11124
the spinal neurons	11147
6 weeks	11169
transplantation	11183
the rats	11200
pentobarbital sodium and a sterile laminectomy	11232
pentobarbital sodium	11232
a sterile laminectomy	11257
vertebral levels L3	11296
the dura	11335
a stereotaxic apparatus	11358
2 μl choleragenoid B subunit-conjugated horseradish peroxidase -LRB- CB-HRP ; List Biological Laboratories , Inc. , CA , USA ; 0.1 % in distilled water -RRB- was injected at this level with a glass electrode using	11383
2 μl choleragenoid B	11383
subunit-conjugated horseradish peroxidase -LRB- CB-HRP ; List Biological Laboratories , Inc. , CA , USA ; 0.1 % in distilled water -RRB-	11404
subunit-conjugated horseradish peroxidase	11404
CB-HRP ; List Biological Laboratories	11447
CB-HRP	11447
List Biological Laboratories	11455
List	11455
Biological Laboratories	11460
Inc. , CA , USA ; 0.1 % in distilled water	11485
Inc. , CA , USA	11485
0.1 % in distilled water	11500
0.1 %	11500
distilled water	11508
this level	11541
a glass electrode using	11557
a glass electrode	11557
1.0 mmlateral to the midline and 1.0 mm	11593
1.0 mmlateral	11593
the midline and 1.0 mm	11610
the midline	11610
1.0 mm	11626
the surface of the dura	11644
the surface	11644
the dura	11659
The solution	11669
1 min	11700
the needle	11710
a further 1 min	11738
the muscle and skin layers	11779
Two to three days	11820
the rats	11845
an overdose of pentobarbital sodium	11877
an overdose	11877
pentobarbital sodium	11892
200 ml of 20 % sucrose in PBS -LRB- pH 7.4 -RRB- , followed by 200 ml of 7 % paraformaldehyde in PBS -LRB- pH 7.4 -RRB-	11951
200 ml	11951
20 % sucrose in PBS -LRB- pH 7.4 -RRB- , followed by 200 ml of 7 % paraformaldehyde in PBS -LRB- pH 7.4 -RRB-	11961
20 % sucrose	11961
PBS -LRB- pH 7.4 -RRB- , followed by 200 ml of 7 % paraformaldehyde in PBS	11976
PBS -LRB- pH 7.4 -RRB-	11976
PBS	11976
pH 7.4	11981
200 ml of 7 % paraformaldehyde in PBS	12002
200 ml	12002
7 % paraformaldehyde in PBS	12012
7 % paraformaldehyde	12012
PBS	12035
pH 7.4	12040
perfusion	12055
the spinal cord	12066
the same fixative for 2 h	12123
the same fixative	12123
2 h	12145
30 % sucrose in PBS	12167
30 % sucrose	12167
PBS	12182
4	12189
°C overnight	12191
The specimen including the adjacent areas rostral and caudal to the implant	12205
The specimen	12205
the adjacent areas rostral and caudal to the implant	12228
the adjacent areas rostral	12228
caudal to the implant	12259
sodium nitroprusside-stabilized tetramethyl benzidine and diaminobenzidine -LRB- Sigma , St Luis , MO , USA -RRB- to visualize HRP-labeled neurons	12320
sodium	12320
nitroprusside-stabilized tetramethyl benzidine and diaminobenzidine	12327
Sigma , St Luis , MO , USA	12396
Sigma	12396
St Luis	12403
MO	12412
USA	12415
HRP-labeled neurons	12434
The number of the labeled neurons in T8 segment	12455
The number	12455
the labeled neurons in T8 segment	12469
the labeled neurons	12469
T8 segment	12492
5 digital photographs taken from different serial sagittal sections under 10 × microscope -LRB- 1.64 mm2 -RRB-	12518
5 digital photographs	12518
different serial sagittal sections under 10 × microscope -LRB- 1.64 mm2 -RRB-	12551
different serial sagittal sections	12551
10 × microscope -LRB- 1.64 mm2 -RRB-	12592
10 × microscope	12592
1.64 mm2	12608
2.6	12619
Behavioral testing Using the BBB locomotor rating scale -LSB- 27 -RSB- , all rats were tested for locomotor function by two observers	12624
Behavioral testing	12624
the BBB locomotor rating scale -LSB- 27	12649
the BBB locomotor rating scale	12649
27	12681
all rats	12686
locomotor function	12711
two observers	12733
the treatment groups	12758
BBB testing	12780
1 week post transplantation	12824
6 weeks post transplantation	12872
6 weeks	12872
2.7	12902
Cortical somatosensory	12907
potentials -LRB- CSEP -RRB- recording and analysis At 6 weeks after transplantation , 15 rats -LRB- n = 5 in each group -RRB- were anesthetized with 3 % sodium pentobarbiturate and stereotaxically fixed followed by an injection of atropine sulfate -LRB- 0.8 mg/kg -RRB-	12937
potentials	12937
CSEP	12949
recording and analysis	12955
6 weeks	12981
transplantation	12995
15 rats -LRB- n = 5 in each group -RRB-	13012
15 rats	13012
n = 5 in each group	13021
n = 5	13021
n	13021
5	13023
each group	13028
3 % sodium pentobarbiturate	13063
an injection of atropine sulfate -LRB- 0.8 mg/kg -RRB-	13128
an injection	13128
atropine sulfate -LRB- 0.8 mg/kg -RRB-	13144
atropine sulfate	13144
0.8 mg/kg	13162
tracheal secretions	13186
Both left and right sciatic nerves	13207
a bipolar platinum wire electrode with positive current pulses of 10 mA magnitude , 0.25 ms duration , and 1 Hz frequency	13277
a bipolar platinum wire electrode with positive current pulses of 10 mA magnitude	13277
a bipolar platinum wire electrode	13277
positive current pulses of 10 mA magnitude	13316
positive current pulses	13316
10 mA magnitude	13343
0.25 ms duration	13360
0.25 ms	13360
duration	13368
1 Hz frequency	13382
CSEP	13398
record	13407
a Neuropack -LRB- Nihon Kohden Co , Japan -RRB- with a monopolar silver-ball placed on the surface of the sensorimotor cortex -LRB- bregma − 2 mm , lateral 2 mm -RRB-	13422
a Neuropack -LRB- Nihon Kohden Co , Japan -RRB-	13422
a Neuropack	13422
Nihon Kohden Co	13435
Japan	13452
a monopolar silver-ball placed on the surface of the sensorimotor cortex	13464
a monopolar silver-ball	13464
the surface of the sensorimotor cortex	13498
the surface	13498
the sensorimotor cortex	13513
bregma − 2 mm , lateral 2 mm	13538
bregma −	13538
2 mm , lateral 2 mm	13546
2 mm	13546
lateral 2 mm	13552
2	13560
The effect of electrical stimulation on CSEP	13567
The effect	13567
electrical stimulation on CSEP	13581
electrical stimulation	13581
CSEP	13607
terms of latency and amplitude	13628
terms	13628
latency and amplitude	13637
potentials	13684
all subjects	13698
the spinal cords	13712
histological processing	13746
2.8	13771
Statistical analysis	13776
statistical analysis of differences between the groups	13801
statistical analysis	13801
differences between the groups	13825
differences	13825
the groups	13845
all quantitative data	13857
means	13911
standard error	13917
Two-tailed student 's t test	13933
Two-tailed student 's	13933
the data between groups	13981
the data	13981
groups	13998
One-way ANOVA followed by Dunnett 's post-hoc multiple comparison tests	14006
One-way ANOVA	14006
Dunnett 's post-hoc multiple comparison tests	14032
Dunnett 's	14032
CSEP	14098
A probability value of Pb0 .05	14104
A probability value	14104
Pb0 .05	14127
Results	14180
1	14193
Distribution and migration of OECs	14196
Distribution and migration	14196
OECs	14226
the contused cord over six weeks on the longitudinal frozen sections	14249
the	14249
cord	14262
six weeks on the longitudinal frozen sections	14272
six weeks	14272
the longitudinal frozen sections	14285
the first three weeks after transplantation	14326
the first three weeks	14326
transplantation	14354
OECs	14371
the lesion site	14396
some of them migrating into the surrounding tissue -LRB- A -- A1 = 1 week ; B -- B1 = 2 weeks ; and C -- C1 = 3 weeks -RRB-	14417
some	14417
them	14425
the surrounding tissue -LRB- A -- A1 = 1 week ; B -- B1 = 2 weeks ; and C -- C1 = 3 weeks -RRB-	14445
the surrounding tissue	14445
A -- A1 = 1 week ; B -- B1 = 2 weeks ; and C -- C1 = 3	14469
A -- A1 = 1 week ; B -- B1 = 2 weeks ; and C -- C1	14469
A1 = 1 week	14471
A1 =	14471
1 week	14474
B -- B1 = 2 weeks ; and C	14482
B	14482
B1 = 2 weeks	14484
B1	14484
= 2 weeks	14486
C	14500
3	14505
weeks	14507
4 weeks after transplantation	14518
4 weeks	14518
transplantation	14532
large cavities	14549
confluence of tissue spaces and cysts	14576
confluence	14576
tissue spaces and cysts	14590
D -- D1	14615
D	14615
D1	14619
OECs	14635
the wall of the cavity	14654
the wall	14654
the cavity	14666
the cavity -LRB- E -- E1 = 5 weeks ; and F -- F1 = 6 weeks -RRB-	14692
the cavity	14692
E -- E1 = 5 weeks ; and F -- F1 = 6 weeks	14704
E	14704
E1 = 5 weeks ; and F -- F1 = 6 weeks	14708
E1 =	14708
5 weeks ; and F -- F1 = 6 weeks	14711
5 weeks	14711
F	14724
some macrophages	14747
OECs	14790
A1 -- F1 are enlargements of the frames in A -- F. Scale bar = 100 μm in A -- F , 220 μm in A1 -- F1 .	14796
A1	14796
F1	14799
enlargements of the frames in A -- F. Scale bar = 100 μm in A -- F , 220 μm in A1 -- F1	14806
enlargements	14806
the frames in A -- F. Scale bar = 100 μm in A -- F , 220 μm in A1 -- F1	14822
the frames	14822
A -- F. Scale bar = 100 μm in A -- F , 220 μm in A1 -- F1	14836
F. Scale bar	14838
= 100 μm in A -- F , 220 μm in A1	14850
= 100 μm	14850
100	14851
A -- F , 220 μm	14861
F , 220 μm	14863
F	14863
220 μm	14866
A1	14876
Fig. 2 .	14884
Fig.	14884
2	14889
The intact and injured tissues of the cord on the coronal plastic sections of the control -LRB- A1 -- A6 -RRB- group and the OEC group -LRB- B1 -- B6 -RRB- .	14892
The intact and injured tissues	14892
the cord on the coronal plastic sections	14926
the cord	14926
the coronal plastic sections	14938
the control -LRB- A1 -- A6 -RRB- group and the OEC group -LRB- B1 -- B6 -RRB-	14970
the control -LRB- A1 -- A6 -RRB- group	14970
A1 -- A6	14983
A1	14983
A6	14986
the OEC group -LRB- B1 -- B6 -RRB-	15000
the OEC group	15000
B1 -- B6	15015
B1	15015
B6	15018
1	15026
week	15028
transplantation	15039
the injured area	15055
both groups -LRB- A1 and B1 -RRB-	15087
both groups	15087
A1 and B1	15100
A1	15100
B1	15107
enlarged	15115
the control group -LRB- A2 and A3 -RRB-	15144
the control group	15144
A2 and A3	15163
A2	15163
A3	15170
the OEC group -LRB- B2 and B3 -RRB- at 2 and 3 weeks	15182
the OEC group -LRB- B2 and B3 -RRB-	15182
the OEC group	15182
B2 and B3	15197
B2	15197
B3	15204
at 2 and 3 weeks	15208
the control animals	15229
most of the cord parenchyma	15249
most	15249
the cord parenchyma	15257
the formation of the large cavity	15299
the formation	15299
the large cavity	15316
4 weeks -LRB- A4 -RRB-	15336
4 weeks	15336
A4	15345
a further decrease of the intact parenchyma	15366
a further decrease	15366
the intact parenchyma	15388
5 weeks -LRB- A5 -RRB- , while the remaining cord still could be seen in the ventral and ventrolateral areas at 6 weeks -LRB- A6 -RRB-	15413
5 weeks -LRB- A5 -RRB-	15413
A5	15422
the remaining cord	15433
the ventral and ventrolateral areas at 6 weeks -LRB- A6 -RRB-	15475
the ventral and ventrolateral areas	15475
6 weeks -LRB- A6 -RRB-	15514
6 weeks	15514
A6	15523
the animals	15531
OECs	15553
the pathology	15567
2 to 6 weeks -LRB- B2 -- B6 -RRB-	15608
2 to 6 weeks	15608
B2 -- B6	15622
B2	15622
B6	15625
the cords	15631
much healthier with less damage and denser parenchyma	15646
much healthier	15646
less damage and denser parenchyma	15666
less damage	15666
denser parenchyma	15682
Scale	15701
200 μm	15711
Fig. 3 .	15720
Fig.	15720
3	15725
The injured area -LRB- A -RRB- , the intact area -LRB- B -RRB- and numbers of myelinated nerve fibers -LRB- C -RRB- of the	15728
The injured area -LRB- A -RRB- , the intact area -LRB- B -RRB- and numbers of myelinated nerve fibers	15728
The injured area -LRB- A -RRB-	15728
The injured area	15728
A	15746
the intact area -LRB- B -RRB-	15750
the intact area	15750
B	15767
numbers of myelinated nerve fibers	15774
numbers	15774
myelinated nerve fibers	15785
C	15810
the	15816
spinal cord receiving DMEM and OEC injections	15829
spinal cord	15829
DMEM and OEC injections	15851
the injured area and the number of myelinated nerve fiber	15885
the injured area	15885
the number of myelinated nerve fiber	15906
the number	15906
myelinated nerve fiber	15920
the intact area	15957
both groups	15986
six weeks post transplantation	16003
six weeks	16003
a statistical difference between the two groups	16034
a statistical difference	16034
the two groups	16067
each time point	16106
+	16123
+	16124
pb0	16127
.01	16130
Fig. 4 .	16136
Fig.	16136
4	16141
The coronal plastic sections showing the myelinated nerve fibers of the spinal cord in the control group -LRB- A1 -- A6 -RRB- and the OEC group -LRB- B1 -- B6 -RRB- .	16144
The coronal plastic sections	16144
the myelinated nerve fibers of the spinal cord in the control group -LRB- A1 -- A6 -RRB- and the OEC group -LRB- B1 -- B6 -RRB-	16181
the myelinated nerve fibers	16181
the spinal cord in the control group -LRB- A1 -- A6 -RRB- and the OEC group -LRB- B1 -- B6 -RRB-	16212
the spinal cord	16212
the control group -LRB- A1 -- A6 -RRB- and the OEC group -LRB- B1 -- B6 -RRB-	16231
the control group	16231
A1 -- A6	16250
A1	16250
A6	16253
the OEC group	16261
B1 -- B6	16276
B1	16276
B6	16279
1 week	16287
a few myelinated nerve fibers scattered in the injured area -LRB- A1 and B1 -RRB- , then	16294
a few myelinated nerve fibers	16294
the injured area -LRB- A1 and B1 -RRB-	16337
the injured area	16337
A1 and B1	16355
A1	16355
B1	16362
number	16385
both groups over following weeks -LRB- A2 -- B6 ; and B2 -- B6 -RRB-	16395
both groups	16395
following weeks -LRB- A2 -- B6 ; and B2 -- B6 -RRB-	16412
following weeks	16412
A2 -- B6 ; and B2 -- B6	16429
A2	16429
B6 ; and B2 -- B6	16432
B6	16432
B2	16440
B6	16443
the number of myelinated nerve fibers	16452
the number	16452
myelinated nerve fibers	16466
the OEC group	16505
the control group at each time point	16527
the control group	16527
each time point	16548
Scale	16565
100 μm	16575
Fig. 5 .	16584
Fig.	16584
5	16589
The photographic picture -LRB- camera lucida -RRB- of the	16592
The photographic picture -LRB- camera lucida -RRB-	16592
The photographic picture	16592
camera lucida	16618
the	16637
cord segment -LRB- A -RRB-	16650
cord segment	16650
A	16664
the injection site -LRB- arrows -RRB- , the cavities -LRB- Ca -RRB- , white -LRB- W -RRB- and graymatter -LRB- G -RRB-	16675
the injection site -LRB- arrows -RRB- , the cavities -LRB- Ca -RRB- , white -LRB- W -RRB- and graymatter	16675
the injection site -LRB- arrows -RRB-	16675
the injection site	16675
arrows	16695
the cavities -LRB- Ca -RRB-	16704
the cavities	16704
Ca	16718
white -LRB- W -RRB-	16723
white	16723
W	16730
graymatter	16737
G	16749
6 weeks after transplantation	16756
6 weeks	16756
transplantation	16770
the longitudinal frozen sections of the cord	16787
the longitudinal frozen sections	16787
the cord	16823
more CB-HRP labeled neurons in the OEC group -LRB- C -RRB- than in the DMEM group -LRB- B -RRB-	16839
more CB-HRP	16839
neurons in the OEC group -LRB- C -RRB-	16859
neurons	16859
the OEC group -LRB- C -RRB-	16870
the OEC group	16870
C	16885
the DMEM group -LRB- B -RRB-	16896
the DMEM group	16896
B	16912
Scale	16916
150 μm	16926
Fig. 6 .	16935
Fig.	16935
6	16940
BBB score in both DMEM and OEC groups from 1 week to 6 weeks after transplantation .	16943
BBB score	16943
both DMEM and OEC groups	16956
DMEM	16961
OEC groups	16970
1 week to 6 weeks after transplantation	16986
1 week	16986
6 weeks after transplantation	16996
6 weeks	16996
transplantation	17010
all animals	17036
gradual improvements	17058
hind limb locomotor function	17082
the six-week recovery period	17118
the BBB score of OEC rats	17148
the BBB score	17148
OEC rats	17165
that of DMEM rats	17190
that	17190
DMEM rats	17198
each time point	17211
+	17228
+ = pb0 .01 and + = pb0 .05	17229
= pb0 .01 and	17230
= pb0	17230
.01 and	17234
= pb0 .05	17243
= pb0	17243
.05	17247
Fig. 7 .	17253
Fig.	17253
7	17258
CSEP	17261
both OECs and DMEM	17287
OECs	17292
DMEM	17301
animals	17315
the sixth week	17326
transplantation	17347
The amplitude	17364
the latency	17396
the normal -LRB- A -RRB-	17434
The difference of the amplitude -LRB- B -RRB- and the latency -LRB- C -RRB- between the DMEM group and the OEC group	17450
The difference	17450
the amplitude -LRB- B -RRB- and the latency -LRB- C -RRB-	17468
the amplitude	17468
B	17483
the latency	17490
C	17503
the DMEM group and the OEC group	17514
the DMEM group	17514
the OEC group	17533
* pb0 .01 compared with normal group , and + pb0 .01	17564
* pb0 .01	17564
pb0	17565
.01	17568
normal group , and + pb0 .01	17586
normal group	17586
+ pb0 .01	17604
+ pb0	17604
.01	17608
the DMED and the OEC groups	17629
the DMED	17629
the OEC groups	17642
3.1	17659
OECs	17664
1 week	17678
contusion of the spinal cord	17691
contusion	17691
the spinal cord	17704
the lesion site	17734
the early stage	17757
they	17782
the wall of the cavity	17816
the wall	17816
the cavity	17828
the cavity	17844
1	17869
week	17871
the contusion	17882
OECs	17897
the epicenter of the lesion and 1-mm rostral and caudal	17925
the epicenter	17925
the lesion and 1-mm rostral and caudal	17942
the lesion	17942
1-mm rostral and caudal	17957
the lesion center	17984
the first three weeks after transplantation -LRB- Fig. 1A -- C , A1 -- C1 -RRB-	18010
the first three weeks	18010
transplantation -LRB- Fig. 1A -- C , A1 -- C1 -RRB-	18038
transplantation	18038
Fig. 1A -- C	18055
Fig. 1A	18055
C	18063
A1 -- C1	18066
A1	18066
C1	18069
OECs	18074
the lesion site	18105
number of macrophage infiltration and appearance of many tissue spaces and cysts	18126
number	18126
macrophage infiltration and appearance	18136
many tissue spaces and cysts	18178
Some of the OECs	18208
Some	18208
the OECs	18216
the surrounding tissue for a short distance	18239
the surrounding tissue	18239
a short distance	18266
4 weeks after transplantation	18287
4 weeks	18287
transplantation	18301
large cavities	18318
confluence of tissue spaces and cysts	18350
confluence	18350
tissue spaces and cysts	18364
the cavities	18396
OECs and macrophages	18409
the wall	18450
the liquid in the cavities -LRB- Fig. 1D , D1 -RRB-	18462
the liquid	18462
the cavities -LRB- Fig. 1D , D1 -RRB-	18476
the cavities	18476
Fig. 1D , D1	18490
Fig. 1D	18490
D1	18499
there	18515
a gradual decrease in number of OECs in both the lesion site and the surrounding tissue , arranging along the wall of the cavity and floated in the cavity -LRB- Fig. 1E -- F , E1 -- F1 -RRB-	18525
a gradual decrease	18525
number of OECs in both the lesion site and the surrounding tissue	18547
number of OECs in both the lesion site	18547
number	18547
OECs in both the lesion site	18557
OECs	18557
both the lesion site	18565
the surrounding tissue	18590
the wall of the cavity	18630
the wall	18630
the cavity	18642
the cavity -LRB- Fig. 1E -- F , E1 -- F1 -RRB-	18668
the cavity	18668
Fig. 1E -- F	18680
Fig. 1E	18680
F	18688
E1 -- F1	18691
E1	18691
F1	18694
Some of the microphages	18699
Some	18699
the microphages	18707
OECs -LRB- Fig. 1F , F1 -RRB-	18749
OECs	18749
Fig. 1F , F1	18755
Fig. 1F	18755
F1	18764
3.2	18769
OECs	18774
the intact tissue of the contused spinal cord	18789
the intact tissue	18789
the contused spinal cord	18810
the	18810
spinal cord	18823
cavity formation in the spinal cord	18855
cavity formation	18855
the spinal cord	18875
1 week	18894
transplantation	18907
the spinal cord	18924
an injured area affecting the dorsal , dorsolateral , and ventrolateral funiculi up to central canal in which lots of macrophages and cysts were found	18947
an injured area	18947
the dorsal , dorsolateral , and ventrolateral funiculi	18973
the dorsal	18973
dorsolateral	18985
ventrolateral funiculi	19003
central canal in which lots of macrophages and cysts were found	19032
central canal	19032
lots of macrophages and cysts	19055
lots	19055
macrophages and cysts	19063
the injured area	19108
fusion of the cysts and formation of micro cavities	19153
fusion	19153
the cysts and formation of micro cavities	19163
the cysts and formation	19163
micro cavities	19190
4 weeks	19209
most of the cord parenchyma	19218
most	19218
the cord parenchyma	19226
the formation of the large cavity resulting in decrease of intact parenchyma of the cord	19270
the formation	19270
the large cavity resulting in decrease of intact parenchyma of the cord	19287
the large cavity	19287
decrease of intact parenchyma of the cord	19317
decrease	19317
intact parenchyma of the cord	19329
intact parenchyma	19329
the cord	19350
the remaining cord	19366
ventral and ventrolateral areas at 6 weeks post transplantation	19408
ventral and ventrolateral areas	19408
6 weeks post transplantation	19443
6 weeks	19443
the above pathological changes	19482
both groups	19526
the cords of the OEC group -LRB- Fig. 2B1 -- B6 -RRB-	19539
the cords	19539
the OEC group -LRB- Fig. 2B1 -- B6 -RRB-	19552
the OEC group	19552
Fig. 2B1 -- B6	19567
Fig. 2B1	19567
B6	19576
less injured tissue and denser parenchyma	19606
less injured tissue	19606
denser parenchyma	19630
those of the DMEM group -LRB- Fig. 2A1 -- A6 -RRB- from week	19653
those	19653
the DMEM group -LRB- Fig. 2A1 -- A6 -RRB- from week	19662
the DMEM group -LRB- Fig. 2A1 -- A6 -RRB-	19662
the DMEM group	19662
Fig. 2A1 -- A6	19678
Fig. 2A1	19678
A6	19687
week	19696
1 to 6 post transplantation	19701
Coronal sections through the injured site	19730
Coronal sections	19730
the injured site	19755
the areas of injured and intact tissue and the cavity size	19797
the areas	19797
injured and intact tissue and the cavity size	19810
injured and intact tissue	19810
the cavity size	19840
both groups	19860
the cavities	19873
the injured sites in different areas	19901
the injured sites	19901
different areas	19922
0.003 mm2	19943
0.02 mm2	19956
the first week that fused to form larger cavities from 0.05 mm2 to 0.16 mm2 during the following two weeks	19972
the first week	19972
larger cavities	20006
0.05 mm2 to 0.16 mm2	20027
0.05 mm2	20027
0.16 mm2	20039
the following two weeks	20055
4 weeks after transplantation	20083
4 weeks	20083
transplantation	20097
the cavity	20113
maximal area of 0.3 mm2 -LRB- Fig. 2A4 , B4 -RRB-	20132
maximal area	20132
0.3 mm2 -LRB- Fig. 2A4 , B4 -RRB-	20148
0.3 mm2	20148
Fig. 2A4 , B4	20157
Fig. 2A4	20157
B4	20167
no significant difference between the control and the OEC groups	20176
no significant difference	20176
the control and the OEC groups	20210
the control	20210
the OEC groups	20226
the area of injured tissue in animals receiving DMEM	20250
the area	20250
injured tissue in animals receiving DMEM	20262
injured tissue	20262
animals receiving DMEM	20280
animals	20280
DMEM	20298
1.35 mm2 at 1	20318
1.35 mm2	20318
1	20330
week	20332
2.02 mm2 at 6 weeks	20340
2.02 mm2	20340
6 weeks	20352
the area of intact tissue	20364
the area	20364
intact tissue	20376
1.47 mm2	20405
0.8 mm2 over 6 weeks -LRB- Fig. 3A , B -RRB-	20417
0.8 mm2	20417
6 weeks -LRB- Fig. 3A , B -RRB-	20430
6 weeks	20430
Fig. 3A , B	20439
Fig. 3A	20439
B	20448
the area of injured tissue in animals receiving OECs increased from 0.41 mm2 to 0.82 mm2	20461
the area	20461
injured tissue in animals receiving OECs increased from 0.41 mm2 to 0.82 mm2	20473
injured tissue	20473
animals receiving OECs increased from 0.41 mm2 to 0.82 mm2	20491
animals	20491
OECs increased from 0.41 mm2 to 0.82 mm2	20509
OECs	20509
0.41 mm2	20529
0.82 mm2	20541
decrease of intact area from 2.41 mm2 to 2 mm2	20567
decrease	20567
intact area from 2.41 mm2 to 2 mm2	20579
intact area	20579
2.41 mm2 to 2 mm2	20596
2.41 mm2	20596
2 mm2	20608
the entire period of six weeks of animal survival	20621
the entire period	20621
six weeks of animal survival	20642
six weeks	20642
animal survival	20655
the statistical significance between the two groups	20671
the statistical significance	20671
the two groups	20708
only at 1	20736
week	20746
transplantation -LRB- pb0 .01 -RRB-	20757
transplantation	20757
pb0 .01	20774
3.3	20783
OECs	20788
the number of myelinated nerve fibers	20803
the number	20803
myelinated nerve fibers	20817
the lesion site	20844
neurons	20874
the rostral segment of the spinal cord	20885
the rostral segment	20885
the spinal cord	20908
the animals	20927
OECs	20949
a few myelinated nerve fibers	20955
the injured area	21008
1 week after transplantation and their number increased during the following weeks -LRB- Fig. 4B1 -- B6 -RRB-	21028
1 week after transplantation	21028
1 week	21028
transplantation	21041
their number increased during the following weeks -LRB- Fig. 4B1 -- B6 -RRB-	21061
their number	21061
the following weeks -LRB- Fig. 4B1 -- B6 -RRB-	21091
the following weeks	21091
Fig. 4B1 -- B6	21112
Fig. 4B1	21112
B6	21121
the fibers	21133
the control animals	21162
the numbers of myelinated nerve fibers	21183
the numbers	21183
myelinated nerve fibers	21198
that of the animals with OECs at each time point	21238
that	21238
the animals with OECs at each time point	21246
the animals	21246
OECs at each time point	21263
OECs	21263
each time point	21271
1	21292
week	21294
6 weeks -LRB- Fig. 4A1 -- A6 -RRB-	21302
6 weeks	21302
Fig. 4A1 -- A6	21311
Fig. 4A1	21311
A6	21320
The semi-quantitative data	21325
the OEC group	21370
the average number of myelinated nerve fibers	21384
the average number	21384
myelinated nerve fibers	21406
50.83 ± 17.14 and 373 ± 77.12	21434
50.83 ± 17.14 and 373	21434
50.83	21434
17.14 and 373	21440
77.12	21454
1 week and 6 weeks respectively , which was significantly greater than that -LRB- 19.50 ± 6.77 and 192.66 ± 49.76 at 1 week and 6 weeks respectively -RRB- in the control group -LRB- pb0 .01 ; Fig. 3C -RRB-	21463
1 week and 6 weeks respectively	21463
1 week and 6 weeks	21463
1 week	21463
6 weeks	21474
that	21533
19.50 ± 6.77 and 192.66 ± 49.76	21540
19.50 ± 6.77	21540
19.50	21540
6.77	21546
192.66 ± 49.76	21555
192.66	21555
49.76	21562
1 week and 6 weeks	21571
1 week	21571
6 weeks	21582
the control group -LRB- pb0 .01 ; Fig. 3C -RRB-	21607
the control group	21607
pb0 .01 ; Fig. 3C	21626
pb0 .01	21626
Fig. 3C	21634
CB-HRP	21644
neurons in both -LRB- DMEM and OEC groups -RRB- were detectable at 6 weeks after transplantation -LRB- Fig. 5 -RRB-	21659
neurons	21659
DMEM and OEC groups	21676
6 weeks	21716
transplantation -LRB- Fig. 5 -RRB-	21730
transplantation	21730
Fig. 5	21747
Their number in T8 segment of the cord	21756
Their number	21756
T8 segment of the cord	21772
T8 segment	21772
the cord	21786
an area of 1.64 mm2	21810
an area	21810
1.64 mm2	21821
different sections	21835
The results	21855
there	21879
96 ± 15 labeled neurons in the OEC group , which was significantly more than 65 ± 13 in the DMEM group -LRB- pb0 .01 -RRB-	21890
96 ± 15	21890
96	21890
15	21893
neurons	21904
the OEC group , which was significantly more than 65 ± 13 in the DMEM group -LRB- pb0 .01 -RRB-	21915
the OEC group	21915
more than 65 ± 13 in the DMEM group -LRB- pb0 .01 -RRB-	21954
more than 65 ± 13	21954
the DMEM group	21973
pb0 .01	21989
3.4	21998
OECs	22003
locomotor performance of the transplanted rats	22017
locomotor performance	22017
the transplanted rats	22042
All animals	22064
gradual improvements	22086
hind limb locomotor function	22110
the six-week recovery period	22146
One week	22176
transplantation	22191
BBB scores for OEC transplanted rats	22208
BBB scores	22208
OEC transplanted rats	22223
7.2 ±	22254
1.27	22258
3.25 ± 1.13 for DMEM injected rats	22276
3.25	22276
± 1.13 for DMEM	22280
± 1.13	22280
DMEM	22290
rats	22304
sixth week after transplantation , OEC	22313
sixth week	22313
transplantation , OEC	22330
transplantation	22330
OEC	22347
transplanted rats	22351
BBB scores of 12.23 ± 1.16	22378
BBB scores	22378
12.23 ± 1.16	22392
10.18 ± 0.96 for DMEM injections	22416
10.18 ± 0.96	22416
DMEM injections	22431
The BBB scores for OEC transplanted rats	22448
The BBB scores	22448
OEC transplanted rats	22467
the controls -LRB- pb0 .01 -RRB- for the first four weeks and pb0 .05 for the last two weeks	22517
the controls -LRB- pb0 .01 -RRB- for the first four weeks	22517
the controls -LRB- pb0 .01 -RRB-	22517
the controls	22517
pb0 .01	22531
the first four weeks	22543
pb0 .05 for the last two weeks	22568
pb0 .05	22568
the last two weeks	22579
Fig. 6	22599
3.5	22608
OECs	22613
recovery of CSEP of the transplanted rats At the end of the sixth week after transplantation , CSEP could be recorded in both OECs and DMEM	22627
recovery	22627
CSEP of the transplanted rats At the end of the sixth week after transplantation , CSEP could be recorded in both OECs and DMEM	22639
CSEP	22639
the transplanted rats At the end of the sixth week after transplantation , CSEP could be recorded in both OECs and DMEM	22647
the transplanted rats	22647
the end of the sixth week after transplantation	22672
the end	22672
the sixth week after transplantation	22683
the sixth week	22683
transplantation	22704
CSEP	22721
both OECs and DMEM	22747
OECs	22752
DMEM	22761
animals	22775
the amplitude	22792
the latency	22824
the normal -LRB- Fig. 7A -RRB-	22862
the normal	22862
Fig. 7A	22874
The amplitude of CSEP in normal rats	22884
The amplitude	22884
CSEP in normal rats	22901
CSEP	22901
normal rats	22909
1.37 ± 0.16 mV , which was significantly higher than 0.42 ± 0.02 mV in the DMEM group and 0.69 ± 0.06 mV in the OEC group	22925
1.37 ± 0.16 mV	22925
1.37	22925
0.16 mV	22930
0.42 ± 0.02 mV in the DMEM group and 0.69 ± 0.06 mV	22975
0.02 mV in the DMEM group	22980
0.02 mV	22980
the DMEM group	22991
0.69 ± 0.06 mV	23010
0.69	23010
0.06 mV	23015
the OEC group	23026
The comparison between the DMEM group and the OEC group	23041
The comparison	23041
the DMEM group and the OEC group	23064
the DMEM group	23064
the OEC group	23083
the significant difference	23115
Fig. 7B	23153
Normal Latency of CSEP	23163
Normal Latency	23163
CSEP	23181
6.05 ± 0.32 ms	23190
6.05	23190
0.32 ms	23195
13.15 ± 1.22 ms in DMEM animals and 10.06 ± 1.04 ms in OECs animals	23231
13.15 ± 1.22 ms in DMEM animals	23231
13.15 ± 1.22 ms	23231
DMEM animals	23248
10.06 ± 1.04 ms in OECs animals	23265
10.06 ± 1.04 ms	23265
OECs animals	23282
the difference between the DMEM group and the OEC group	23305
the difference	23305
the DMEM group and the OEC group	23328
the DMEM group	23328
the OEC group	23347
Fig. 7C	23378
Discussion	23392
this study	23406
GFP-expressing OECs	23418
contused spinal cord of rats	23461
contused spinal cord	23461
rats	23485
The results	23491
several novel insights	23510
OECs	23540
injured spinal cord	23555
relations	23584
the cavity	23599
macrophage invasion and cavity formation in the host spinal cord after the contusion	23619
macrophage invasion and cavity formation	23619
the host spinal cord after the contusion	23663
the host spinal cord	23663
the contusion	23690
OECs	23705
the contused cord	23722
the	23722
cord	23735
the normal cord tissue	23756
smaller numbers	23787
short distance	23810
It	23826
damaged spinal cord tissue is unfavorable for OECs	23845
damaged spinal cord tissue	23845
unfavorable for OECs	23875
unfavorable	23875
OECs	23891
The toxicity of the lesion site to transplanted OECs	23920
The toxicity	23920
the lesion site to transplanted OECs	23936
the lesion site	23936
transplanted OECs	23955
differences in the survival rate -LSB- 28 -RSB-	23998
differences	23998
the survival rate -LSB- 28 -RSB-	24013
the survival rate	24013
28 -RSB-	24032
That	24037
the timing of OECs transplantation	24049
the timing	24049
OECs transplantation	24063
7 days	24102
contusion	24115
the time of injury	24149
the time	24149
injury	24161
29 -RSB-	24169
in vitro apoptosis of OECs	24186
in vitro apoptosis	24186
OECs	24208
acutely injured spinal cord explants	24263
delayed injury explants -LSB- 30 -RSB-	24312
delayed injury explants	24312
30 -RSB-	24337
In vivo OECs transplanted into the injured spinal cord	24342
In vivo OECs	24342
the injured spinal cord	24373
24 h -LSB- 31 -RSB-	24418
24 h	24418
31 -RSB-	24424
Previous studies	24429
bulb-derived OECs	24465
the host spinal cord for 2 to 8 months -LSB- 32 -- 34 -RSB-	24498
the host spinal cord	24498
2 to 8 months -LSB- 32 -- 34 -RSB-	24523
2 to 8 months	24523
32 -- 34	24538
3 months only 2.3	24553
1.4 % of the OECs	24571
1.4 %	24571
the OECs	24579
the number transplanted -LSB- 35 -RSB-	24602
the number transplanted	24602
35 -RSB-	24627
OECs	24641
the host tissue	24663
up to 700 μm	24679
the lesion epicenter at sevendays	24697
the lesion epicenter	24697
sevendays	24721
transplantation -LSB- 36 -RSB-	24737
transplantation	24737
36 -RSB-	24754
It	24759
OECswere	24785
lesion site	24808
most cells	24821
the injection	24854
lesion site	24869
OECs	24891
2.5-mm outside of the lesion site	24905
2.5-mm outside	24905
the lesion site	24923
the lesion	24951
OECs	24974
injury signals	24997
axonal re-growth	25036
the lesion -LSB- 37 -RSB-	25075
the lesion	25075
37 -RSB-	25087
It	25092
survival and migration	25126
OECs	25150
the intact tissue of contused spinal cord , which has been confirmed previously -LSB- 29,38	25177
the intact tissue	25177
contused spinal cord , which has been confirmed previously -LSB- 29,38	25198
contused spinal cord	25198
29,38	25257
the same time	25268
a significant reduction in the injured area	25283
a significant reduction	25283
the injured area	25310
1 week to 6 weeks only	25342
1 week	25342
6 weeks only	25352
OEC transplantation -LRB- Figs. 2 and 3A and B -RRB-	25371
OEC transplantation	25371
Figs. 2 and 3A and B	25392
Figs. 2	25392
3A and B	25404
addition	25418
neurons labeled by CB-HRP in rostral segment to the lesion sites	25428
neurons	25428
CB-HRP in rostral segment	25447
CB-HRP	25447
rostral segment	25457
the lesion sites	25476
number	25511
OEC transplantation -LRB- Fig. 3C -RRB-	25524
OEC transplantation	25524
Fig. 3C	25545
These data	25555
the spinal tissue	25586
particular ventrolateral white matter	25616
the locomotor capacity of spinal cord injured rats -LSB- 39 -RSB-	25684
the locomotor capacity	25684
spinal cord injured rats -LSB- 39 -RSB-	25710
spinal cord	25710
rats -LSB- 39 -RSB-	25730
rats	25730
39 -RSB-	25736
these facts with more neurons	25747
these facts	25747
more neurons	25764
it	25787
OECs	25812
secondary tissue degeneration	25828
spinal cord injury	25864
The mechanism of such a restorative role of OECs	25884
The mechanism	25884
such a restorative role of OECs	25901
such a restorative role	25901
OECs	25928
it	25949
neurotrophic factors such as BDNF , NGF , GDNF , and NT-4	25981
neurotrophic factors	25981
BDNF , NGF , GDNF , and NT-4	26010
BDNF	26010
NGF , GDNF , and NT-4	26016
5 expressed by OECs	26036
5	26036
OECs	26051
14,15	26073
BDNF	26081
tissue necrosis	26111
spinal cord injury -LSB- 40 -RSB-	26133
spinal cord injury	26133
40 -RSB-	26153
sensory axons	26176
rubrospinal and cortico-spinal axons	26191
NGF , BDNF , and NT-3 -LSB- 16 -- 18,41,42 -RSB-	26246
NGF	26246
BDNF	26251
NT-3 -LSB- 16	26261
NT-3	26261
16	26267
18,41,42 -RSB-	26270
NT-4	26281
5	26286
atrophy of rat rubrospinal neurons	26297
atrophy	26297
rat rubrospinal neurons	26308
axotomy	26338
rubrospinal regeneration	26359
19 -RSB-	26385
Gorrie et al.	26400
Gorrie	26400
et al.	26407
the astrogliosis in OECs transplanted animals was reduced , suggesting modulation of the inflammation in the spinal cord , which is an important process removing cellular debris after injury and may be beneficial in reducing secondary damage to the cord	26433
the astrogliosis	26433
OECs transplanted animals was reduced , suggesting modulation of the inflammation in the spinal cord , which is an important process removing cellular debris after injury and may be beneficial in reducing secondary damage to the cord	26453
OECs	26453
transplanted animals	26458
modulation of the inflammation in the spinal cord , which is an important process removing cellular debris after injury	26503
modulation	26503
the inflammation in the spinal cord , which is an important process removing cellular debris after injury	26517
the inflammation	26517
the spinal cord , which is an important process removing cellular debris after injury	26537
the spinal cord	26537
an important process removing cellular debris after injury	26563
an important process	26563
cellular debris	26593
injury	26615
secondary damage	26656
the cord	26676
43 -RSB-	26686
the present study	26694
the number of myelinated nerve fibers	26713
the number	26713
myelinated nerve fibers	26727
the OEC group	26775
the control group over sixweek survival	26797
the control group	26797
sixweek survival	26820
The increase of myelinated nerve fibers in the injured area	26838
The increase	26838
myelinated nerve fibers in the injured area	26854
myelinated nerve fibers	26854
the injured area	26881
the re-myelination of the fibers	26912
the re-myelination	26912
the fibers	26934
SCI	26951
it	26967
Schwann cells	26996
OECs	27011
the nerve fibers	27033
SCI -LSB- 44 , also review in Ref	27056
SCI -LSB- 44	27056
SCI	27056
44	27061
review in Ref	27070
review	27070
Ref	27080
45 -RSB- , which is important because remaining deficits after injury	27085
45 -RSB-	27085
remaining deficits after injury	27117
remaining deficits	27117
injury	27142
demyelination of spared axons -LSB- 46 -RSB-	27170
demyelination	27170
spared axons -LSB- 46 -RSB-	27187
spared axons	27187
46 -RSB-	27201
these anatomical evidences	27215
functional improvements in the locomotor ability -LSB- 33,47 -RSB-	27268
functional improvements	27268
the locomotor ability -LSB- 33,47 -RSB-	27295
the locomotor ability	27295
33,47 -RSB-	27318
it	27326
the remyelination	27346
a role in the improvement at the early stage	27372
a role	27372
the improvement at the early stage	27382
the improvement	27382
the early stage	27401
OEC transplantation as time needed	27423
OEC transplantation	27423
time needed	27446
time	27446
We	27459
early improvement of the spinal cord function	27475
early improvement	27475
the spinal cord function	27496
the neurotrophic factors	27542
the host tissue evoked by the transplantation and the OECs	27572
the host tissue	27572
the transplantation and the OECs	27598
the transplantation	27598
the OECs	27622
the remyelination	27640
the function of the injured cord	27677
the function	27677
the injured cord	27693
a later stage	27713
this late effect	27736
the neurotrophic factors	27772
the primary causes of human SCI	27801
the primary causes	27801
human SCI	27823
automobile collisions	27837
violence	27872
injuries in sporting events , in SCI patients the contusive injury rarely transects the cord completely , even neural functions caudal to the level of injury	27893
injuries	27893
events	27914
SCI patients	27925
the contusive injury	27938
the cord	27976
neural functions	28002
the level of injury	28029
the level	28029
injury	28042
reference 48 -RSB-	28081
reference	28081
contusion	28102
sequential pathological changes including hemorrhage , edema , axonal and neuronal necrosis , and demyelination followed by cavity formation	28113
sequential pathological changes	28113
hemorrhage , edema , axonal and neuronal necrosis , and demyelination followed by cavity formation	28155
hemorrhage	28155
edema , axonal and neuronal necrosis	28167
demyelination followed by cavity formation	28208
demyelination	28208
cavity formation	28234
the lesion site which is invaded by massive number of macrophages and other polymorphonuclear cells -LSB- 34,49,50 -RSB-	28268
the lesion site	28268
massive number of macrophages and other polymorphonuclear cells -LSB- 34,49,50 -RSB-	28304
massive number of macrophages	28304
massive number	28304
macrophages	28322
other polymorphonuclear cells -LSB- 34,49,50 -RSB-	28338
other polymorphonuclear cells	28338
34,49,50 -RSB-	28369
this study	28383
all these cytopathological changes	28395
the anatomical structure of the cord	28452
the anatomical structure	28452
the cord	28480
the cavity	28507
the OEC transplantation	28541
The result about the cavity	28566
The result	28566
the cavity	28583
that reported by Plant , et al in 2003 -LSB- 29 -RSB- and Ramer , et al in 2004 -LSB- 36 -RSB- , in which they transplanted bulb - and mucosa-derived OECs into the contused T9 -- T10 segment and crushed C4 segment of the rat cord	28612
that reported by Plant	28612
that	28612
Plant	28629
et al in 2003 -LSB- 29	28636
et al	28636
2003 -LSB- 29	28645
Ramer , et al in 2004 -LSB- 36 -RSB- , in which they transplanted bulb - and mucosa-derived OECs into the contused T9 -- T10 segment and crushed C4 segment of the rat cord	28659
Ramer , et al in 2004 -LSB- 36 -RSB- , in which they transplanted bulb - and mucosa-derived OECs into the contused T9	28659
Ramer	28659
et al in 2004 -LSB- 36 -RSB-	28666
et al	28666
2004 -LSB- 36 -RSB-	28675
2004 -LSB-	28675
they	28695
bulb - and mucosa-derived OECs	28713
the contused T9	28748
T10 segment and crushed C4 segment of the rat cord	28764
T10 segment and crushed C4 segment	28764
the rat cord	28802
a significant decrease of cavity size.We	28821
a significant decrease	28821
cavity size.We	28847
the differencemay result from that the degree of injury caused by the contusion and the crush	28875
the differencemay result	28875
the degree of injury	28910
the degree	28910
injury	28924
the contusion and the crush	28941
the contusion	28941
the crush	28959
the contusion an impact force of 10 g-25 cm was imposed in this study	28991
the contusion	28991
an impact force of 10 g-25 cm	29005
an impact force	29005
10 g-25 cm	29024
this study	29050
that of 10 g-12.5 mm in Plant	29076
that	29076
10 g-12.5 mm in Plant	29084
10 g-12.5 mm	29084
Plant	29100
et al in 2003 -LSB- 29 -RSB- , which resulted in 9.9 % and 23 %	29107
et al	29107
2003 -LSB- 29 -RSB- , which resulted in 9.9 % and 23 %	29116
2003	29116
29 -RSB- , which resulted in 9.9 % and 23 %	29122
29 -RSB-	29122
9.9 % and 23 %	29145
9.9 %	29145
23 %	29154
tissue	29165
26 -RSB-	29186
the number of transplanted OECs , 120,000 and 150,000 used previously and 90,000 in the current study	29201
the number of transplanted OECs , 120,000 and 150,000 used previously	29201
the number	29201
transplanted OECs , 120,000 and 150,000 used previously	29215
transplanted OECs	29215
120,000 and 150,000 used previously	29234
120,000 and 150,000	29234
90,000 in the current study	29274
90,000	29274
the current study	29284
the difference	29320
the relation of the cell number and the repair	29346
the relation	29346
the cell number and the repair	29362
the cell number	29362
the repair	29382
the future study	29418
the cavity formation in the contused spinal cord	29445
the cavity formation	29445
the contused spinal cord	29469
the OEC transplantation	29515
all animals receiving OECs	29540
all animals	29540
OECs	29562
better functional performance	29577
these of the control animals	29612
these	29612
the control animals	29621
BBB testing	29648
the first 4 weeks	29679
OECs transplantation , which was confirmed previously by Ruitenberg , et al. , 2003 -LSB- 46 -RSB-	29703
OECs transplantation	29703
Ruitenberg , et al. , 2003 -LSB- 46 -RSB-	29759
Ruitenberg	29759
et al.	29771
2003	29779
46 -RSB-	29785
the sixth week CSEP in OECs-injected animals	29805
the sixth week CSEP	29805
OECs-injected animals	29828
their amplitude and latency	29889
both BBB testing and CSEP recording	29926
the function of the contused spinal cord	29976
the function	29976
the contused spinal cord	29992
the	29992
spinal cord	30005
normal level	30038
We	30052
spinal cord function	30077
the protective potential of OECs on the host tissue	30114
the protective potential	30114
OECs on the host tissue	30142
OECs	30142
the host tissue	30150
It	30167
a fact	30173
more intact tissue , more fibers , more preserved neurons and smaller lesion size	30192
more intact tissue	30192
more fibers	30212
more preserved neurons	30225
smaller lesion size	30252
the tissue of the injured spinal cord	30273
the tissue	30273
the injured spinal cord	30287
animals receiving OECs transplantation	30333
animals	30333
OECs transplantation	30351
The correlation between the lesion size and the functional performance	30373
The correlation	30373
the lesion size and the functional performance	30397
the lesion size	30397
the functional performance	30417
26,38,46 -RSB-	30478
the lesion size	30505
impaired hind limb performance	30541
we	30579
the OECs-mediated tissue preservation	30595
the functional recovery , which may contribute more to the functional recovery than nerve regeneration and axon remyelination at early stages after implantation	30646
the functional recovery	30646
more to the functional recovery than nerve regeneration and axon remyelination	30692
the functional recovery than nerve regeneration and axon	30700
the functional recovery	30700
nerve regeneration and axon	30729
early stages	30774
implantation	30793
